Premium
Company Profiles
Author(s) -
Daud, A,
Joshua, A. M,
Dronca, R,
Patnaik, A,
Zarour, H,
Kefford, R,
Lindia, J,
Li, X. N,
Ebbinghaus, S,
Kang, S. P,
Hamid, O,
Ribas, A,
Robert, C,
Hodi, F. S,
Wolchok, J,
Hwu, W-J,
Weber, J. S,
Gangadhar, T. C,
Joseph, R
Publication year - 2015
Publication title -
asia‐pacific journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 29
eISSN - 1743-7563
pISSN - 1743-7555
DOI - 10.1111/ajco.12377
Subject(s) - business
At Janssen, we collaborate with the world for the health of everyone in it. What matters most to us is a healthy outcome for each patient. We’re committed to providing safe and effective medicines as well as the services and support that contribute to healthy outcomes. Now the fastest growing of the top 10 pharmaceutical companies globally, we’re focusing our unique model of innovation on some of the most devastating diseases and the most complex medical challenges of our time, across five therapeutic areas; Immunology, Oncology, Neuroscience, Cardiovascular Medicine, and Infectious Disease. More information can be found at www.janssen.com.au